We are live on ! Find out more
OLVIG

Oliver Lagore Vanvalin Investment Group Portfolio holdings

AUM $255M
This Fund
S&P 500
This Quarter Est. Return
-11.04%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$171M
AUM Growth
+$22.2M
Cap. Flow
+$45.8M
Cap. Flow %
26.71%
Top 10 Hldgs %
55.94%
Holding
748
New
149
Increased
171
Reduced
131
Closed
51

Sector Composition

Rank Sector Weight
1 Technology 3.43%
2 Consumer Discretionary 2.78%
3 Utilities 2.58%
4 Industrials 2.29%
5 Consumer Staples 2.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JOAN
726
DELISTED
JOANN, Inc. Common Stock
JOAN
$0 ﹤0.01%
12
NVTA
727
DELISTED
Invitae Corporation
NVTA
$0 ﹤0.01%
50
FATH.WS
728
DELISTED
Fathom Digital Manufacturing Corporation Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50 per share
FATH.WS
$0 ﹤0.01%
200
CPUH.WS
729
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$0 ﹤0.01%
100
HEXO
730
DELISTED
HEXO Corp. Common Shares
HEXO
$0 ﹤0.01%
+155
New +$740
OWLT.WS
731
DELISTED
Owlet, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
OWLT.WS
$0 ﹤0.01%
150
RIDE
732
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
0
SI
733
DELISTED
Silvergate Capital Corporation
SI
$0 ﹤0.01%
5
-95
-95% -$8.86K
BOXD.WS
734
DELISTED
Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share
BOXD.WS
$0 ﹤0.01%
100
EPHYW
735
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
$0 ﹤0.01%
300
TPGY
736
DELISTED
TPG Pace Beneficial Finance Corp.
TPGY
$0 ﹤0.01%
4
CRU.WS
737
DELISTED
Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CRU.WS
$0 ﹤0.01%
100
IPOF.WS
738
DELISTED
Social Capital Hedosophia Holdings Corp. VI Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOF.WS
$0 ﹤0.01%
100
ENDP
739
DELISTED
Endo International plc
ENDP
$0 ﹤0.01%
100
HZNP
740
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$0 ﹤0.01%
+3
New +$284
FBC
741
DELISTED
Flagstar Bancorp, Inc. New
FBC
$0 ﹤0.01%
3

Similar funds

Oliver Lagore Vanvalin Investment Group's Q2 2022 Portfolio in Review

As of Q2 2022, Oliver Lagore Vanvalin Investment Group held 748 positions worth $171M, up 15% from $149M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Oliver Lagore Vanvalin Investment Group deployed $45.8M of net new capital in Q2 2022, opening 149 new positions and adding to 171 existing holdings. Its largest new stake was Vanguard Health Care ETF: 16,422 shares worth $3.87M.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 5.1% a quarter earlier, followed by Consumer Discretionary and Utilities.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.84M trimmed.

  • Oliver Lagore Vanvalin Investment Group's largest Q2 2022 buy was Vanguard Health Care ETF: 16,422 shares worth $3.87M.
  • Oliver Lagore Vanvalin Investment Group added most to iShares 1-3 Year Treasury Bond ETF in Q2 2022, an estimated $21.7M increase.
  • Oliver Lagore Vanvalin Investment Group's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.84M.
  • Oliver Lagore Vanvalin Investment Group fully exited Vanguard Short-Term Corporate Bond ETF in Q2 2022, selling an estimated $486K.
  • Oliver Lagore Vanvalin Investment Group's ten largest holdings make up 56% of its $171M portfolio in Q2 2022.
  • Oliver Lagore Vanvalin Investment Group opened 149 new positions and closed 51 in Q2 2022.
  • Oliver Lagore Vanvalin Investment Group's portfolio value rose 15% quarter-over-quarter to $171M.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2022, filed 16 Aug 2022.